Nucleic acid amplification testing (NAAT) is the recommended method for initial screening or testing for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections. Neisseria gonorrhoeae (NG) culture is recommended plus NAAT when suspecting antimicrobial resistance, test of cure, symptomatic patients, pelvic inflammatory disease (PID ...

4 天之前 · Diagnosis of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis infections. Vaginal, endocervical, or male urethral swab, first-void urine (patient should not have urinated for one hour prior to specimen collection), or cervical cells in liquid cytology vial.

Ct/GC: Option 1: Gen-Probe® Aptima® endocervical or vaginal swab. Endocervical swab: Remove excess mucus from the cervical os and surrounding mucosa using the cleaning swab (white-shaft swab in the package with red printing).

The Xpert® CT/NG test is a qualitative in vitro real-time PCR test for the automated detection and differentiation of genomic DNA from Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (NG) to aid in the diagnosis of chlamydial and gonorrheal disease in the urogenital tract and extragenital sites (pharynx and rectum).

Who should be tested for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG)? According to the Centers for Disease Control (CDC), sexually active women 24 years old or younger should be screened for urogenital CT/NG.

If confirmation of positive results by an alternate nucleic acid target is required, refer to Chlamydia trachomatis and Neisseria gonorrhoeae (CTNG) by Transcription-Mediated Amplification (TMA) with Reflex to CT/NG Confirmation .

4 天之前 · Vaginal swab: Care provider specimen: Collect vaginal fluid sample using the GenProbe® Aptima® vaginal swab kit by contacting the swab to the lower third of the vaginal wall and rotating the swab for 10 to 30 seconds to absorb fluid. Immediately place the swab into the transport tube and carefully break the swab shaft against the side of the ...

This nucleic acid amplification test (NAAT) detects genomic DNA from Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) using qualitative real-time PCR. This test is approved by the USA Food and Drug Administration for endocervical swab specimens and male and female urine specimens.

Endocervical or urethral swab: Follow instructions in the Aptima Unisex Swab Specimen Collection Kit (white label). In females, to ensure collection of cells infected with N. gonorrhoeae/C. trachomatis, columnar epithelial cells lining the endocervix should be obtained. Excess mucus should be removed prior to sampling.

Nucleic Acid Amplification Test (NAAT) for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) using the following platforms: NOTE: Studies have shown that the optimal specimen for men is urine and for women is vaginal swab. Inpatient and ED: Urine: Collected in Xpert Urine Specimen Collection Kit.